TheraVision: Engineering platform technology for the development of oncolytic viruses based on herpes simplex virus type 1.
Funk C, Uhlig N, Ruzsics Z, Baur F, Peindl M, Nietzer S, Epting K, Vacun G, Dandekar G, Botteron C, Werno C, Grunwald T, Bailer SM.
Funk C, et al. Among authors: epting k.
Mol Ther Oncol. 2024 Feb 28;32(1):200784. doi: 10.1016/j.omton.2024.200784. eCollection 2024 Mar 21.
Mol Ther Oncol. 2024.
PMID: 38596296
Free PMC article.